investors.connectbiopharm.com Open in urlscan Pro
2a02:26f0:e300::211:93b0  Public Scan

URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Submission: On June 02 via api from US — Scanned from DE

Summary

This website contacted 14 IPs in 4 countries across 12 domains to perform 40 HTTP transactions. The main IP is 2a02:26f0:e300::211:93b0, located in Prague, Czech Republic and belongs to AKAMAI-ASN1, NL. The main domain is investors.connectbiopharm.com.
TLS certificate: Issued by R3 on May 9th 2024. Valid for: 3 months.
This is the only time investors.connectbiopharm.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

Apex Domain
Subdomains
Transfer
19 connectbiopharm.com
investors.connectbiopharm.com
www.connectbiopharm.com
794 KB
7 gstatic.com
fonts.gstatic.com
138 KB
3 googleapis.com
fonts.googleapis.com — Cisco Umbrella Rank: 33
4 KB
2 adobedtm.com
assets.adobedtm.com — Cisco Umbrella Rank: 425
63 KB
2 fontawesome.com
use.fontawesome.com — Cisco Umbrella Rank: 1230
17 KB
1 nr-data.net
bam.nr-data.net — Cisco Umbrella Rank: 245
623 B
1 newrelic.com
js-agent.newrelic.com — Cisco Umbrella Rank: 636
17 KB
1 omtrdc.net
thomsonreuterscorporategroupweb.sc.omtrdc.net — Cisco Umbrella Rank: 42316
344 B
1 demdex.net
dpm.demdex.net — Cisco Umbrella Rank: 243
675 B
1 google-analytics.com
region1.google-analytics.com — Cisco Umbrella Rank: 2533
263 B
1 globenewswire.com
ml.globenewswire.com — Cisco Umbrella Rank: 80335
234 B
1 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 39
93 KB
40 12
Domain Requested by
17 investors.connectbiopharm.com investors.connectbiopharm.com
7 fonts.gstatic.com fonts.googleapis.com
3 fonts.googleapis.com investors.connectbiopharm.com
2 www.connectbiopharm.com investors.connectbiopharm.com
2 assets.adobedtm.com investors.connectbiopharm.com
assets.adobedtm.com
2 use.fontawesome.com investors.connectbiopharm.com
1 bam.nr-data.net js-agent.newrelic.com
1 js-agent.newrelic.com investors.connectbiopharm.com
1 thomsonreuterscorporategroupweb.sc.omtrdc.net investors.connectbiopharm.com
1 dpm.demdex.net assets.adobedtm.com
1 region1.google-analytics.com www.googletagmanager.com
1 ml.globenewswire.com investors.connectbiopharm.com
1 www.googletagmanager.com investors.connectbiopharm.com
40 13

This site contains links to these domains. Also see Links.

Domain
www.connectbiopharm.com
www.globenewswire.com
Subject Issuer Validity Valid
leapfrog-ssl-42.gcs-web.com
R3
2024-05-09 -
2024-08-07
3 months crt.sh
use.fontawesome.com
Cloudflare Inc ECC CA-3
2023-10-12 -
2024-10-10
a year crt.sh
upload.video.google.com
WR2
2024-05-13 -
2024-08-05
3 months crt.sh
*.google-analytics.com
WR2
2024-05-13 -
2024-08-05
3 months crt.sh
pro.globenewswire.com
R3
2024-04-29 -
2024-07-28
3 months crt.sh
assets.adobedtm.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-07-11 -
2024-08-10
a year crt.sh
*.gstatic.com
WR2
2024-05-13 -
2024-08-05
3 months crt.sh
connectbiopharm.com
Go Daddy Secure Certificate Authority - G2
2024-05-17 -
2025-06-18
a year crt.sh
*.demdex.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-09-26 -
2024-10-26
a year crt.sh
*.sc.omtrdc.net
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2024-02-07 -
2025-03-09
a year crt.sh
js-agent.newrelic.com
GlobalSign Atlas R3 DV TLS CA 2024 Q1
2024-03-21 -
2025-04-22
a year crt.sh
*.nr-data.net
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-09-29 -
2024-10-01
a year crt.sh

This page contains 1 frames:

Primary Page: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Frame ID: B6E3294BD31157C81DD3BFBC76DC4999
Requests: 42 HTTP requests in this frame

Screenshot

Page Title

Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma | Connect Biopharma Holdings Ltd

Detected technologies

Overall confidence: 100%
Detected patterns
  • /wp-(?:content|includes)/

Overall confidence: 100%
Detected patterns

Overall confidence: 100%
Detected patterns
  • (?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)

Overall confidence: 100%
Detected patterns

Overall confidence: 100%
Detected patterns
  • googletagmanager\.com/gtag/js

Overall confidence: 100%
Detected patterns
  • ([\d.]+)?/modernizr(?:\.([\d.]+))?.*\.js

Page Statistics

40
Requests

100 %
HTTPS

69 %
IPv6

12
Domains

13
Subdomains

14
IPs

4
Countries

1128 kB
Transfer

3838 kB
Size

6
Cookies

Redirected requests

There were HTTP redirect chains for the following requests:

40 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request connect-biopharma-announces-positive-rademikibart-global-phase
investors.connectbiopharm.com/news-releases/news-release-details/
86 KB
26 KB
Document
General
Full URL
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93b0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
2cfba530cee6ca61a69c10b2af0fdc35d3b39e008756e47acb0770b0276b4d4a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

Accept-Ranges
bytes
Cache-Control
public, max-age=0, s-maxage=2700
Connection
keep-alive
Content-Encoding
gzip
Content-Language
en
Content-Length
23912
Content-Type
text/html; charset=UTF-8
Date
Sun, 02 Jun 2024 08:44:12 GMT
ETag
"1717317852"
Expect-CT
max-age=0, report-uri="/report-expect-ct-violation"
Expires
Sun, 02 Jun 2024 08:44:12 GMT
Feature-Policy
accelerometer 'none';ambient-light-sensor 'none';autoplay 'self';camera 'none';encrypted-media 'none';fullscreen 'self';geolocation 'self';gyroscope 'none';magnetometer 'none';microphone 'none';midi 'none';payment 'none';picture-in-picture 'none';speaker 'self';sync-xhr 'self';usb 'none';vibrate 'none';vr 'none'
From-Origin
same
Last-Modified
Sun, 02 Jun 2024 08:44:12 GMT
Referrer-Policy
no-referrer-when-downgrade
Strict-Transport-Security
max-age=31536000
Vary
Accept-Encoding
X-Age
0
X-Akamai-Transformed
9 23781 0 pmb=mTOE,2
X-Content-Type-Options
nosniff
X-Drupal-Dynamic-Cache
UNCACHEABLE
X-EdgeConnect-MidMile-RTT
8
X-EdgeConnect-Origin-MEX-Latency
372
X-Frame-Options
SAMEORIGIN
X-Request-ID
v-48dfb360-20bc-11ef-bfe8-93733c3c3864
X-XSS-Protection
1; mode=block
css_aS5d2lco9Rphp53_qC_evvbP56kmHXoHzc5zFbxW1aY.css
investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/
44 KB
8 KB
Stylesheet
General
Full URL
https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/css_aS5d2lco9Rphp53_qC_evvbP56kmHXoHzc5zFbxW1aY.css?delta=0&language=en&theme=nir_pid3975&include=eJyVkmtOwzAMxy-0tRIIIc7BAaI8vNY0tYfjbhqnx32ItduQQP2Q-Od__YoJxcUOEiqLS17tCxlKfb3uyCS9lw50EriQOXZ1D56cQOS-BzKOTC62XvQXvSefL0WdmJQaF7z8Q17cVMsuskCdZDj6_A46edasOgo3AmWpeciKvbXm6625KxYZ-jr4ApNyvNQFk1yt8YKRaYn_8TmAXKoBqyMXHJu95RY3czPTnhMI4ZdsilMeYgsnIC17haKbCExxXQtkiPpUZQzi5XLnuAJTzHGQ1HJamoEseRnZjSP42AUm2ClztvnXy1nZAw530JPi_pDRlkNundsxreERn99eX-qY0dpckzOmBqzxsd4Zp4nzCUQwwQbOv-9b8NbKI8-BWW88vyWweSeepWcI9nbgiBWj7fgDVi3npJ920MxZ-WNVPnEAl_1Asf2D0JYyfQMmlE9n
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93b0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
13d34328726aed561a381ccc2465ab465c8f424ec0b13fb600ab3b5431a21280
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Expires
Sun, 02 Jun 2024 08:47:12 GMT
X-EdgeConnect-Origin-MEX-Latency
95
Date
Sun, 02 Jun 2024 08:44:12 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
X-EdgeConnect-MidMile-RTT
7
X-Age
1099530
Connection
keep-alive
Content-Length
7823
X-Request-ID
v-2a953fd6-01b5-11ef-bf34-dfb93666b842
Last-Modified
Sat, 13 Apr 2024 09:50:56 GMT
Vary
Accept-Encoding
Content-Type
text/css
Cache-Control
max-age=180
Accept-Ranges
bytes
X-Cache-Hits
1202
css_WMJ-iBmnx_tEgHQzxcD_UHCCZmLpNYno2PDmmTUdXys.css
investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/
210 KB
29 KB
Stylesheet
General
Full URL
https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/css_WMJ-iBmnx_tEgHQzxcD_UHCCZmLpNYno2PDmmTUdXys.css?delta=1&language=en&theme=nir_pid3975&include=eJyVkmtOwzAMxy-0tRIIIc7BAaI8vNY0tYfjbhqnx32ItduQQP2Q-Od__YoJxcUOEiqLS17tCxlKfb3uyCS9lw50EriQOXZ1D56cQOS-BzKOTC62XvQXvSefL0WdmJQaF7z8Q17cVMsuskCdZDj6_A46edasOgo3AmWpeciKvbXm6625KxYZ-jr4ApNyvNQFk1yt8YKRaYn_8TmAXKoBqyMXHJu95RY3czPTnhMI4ZdsilMeYgsnIC17haKbCExxXQtkiPpUZQzi5XLnuAJTzHGQ1HJamoEseRnZjSP42AUm2ClztvnXy1nZAw530JPi_pDRlkNundsxreERn99eX-qY0dpckzOmBqzxsd4Zp4nzCUQwwQbOv-9b8NbKI8-BWW88vyWweSeepWcI9nbgiBWj7fgDVi3npJ920MxZ-WNVPnEAl_1Asf2D0JYyfQMmlE9n
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93b0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
b0c464205a5f66b884fc0456a06ee754b60469cc929950cd91b5b4128f4f5e1b
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Expires
Sun, 02 Jun 2024 08:47:02 GMT
X-EdgeConnect-Origin-MEX-Latency
92
Date
Sun, 02 Jun 2024 08:44:12 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
X-EdgeConnect-MidMile-RTT
7
X-Age
49871
Connection
keep-alive
Content-Length
29132
X-Request-ID
v-90955c96-01ae-11ef-b249-5745e02444cb
Last-Modified
Sat, 13 Apr 2024 09:50:56 GMT
Vary
Accept-Encoding
Content-Type
text/css
Cache-Control
max-age=170
Accept-Ranges
bytes
X-Cache-Hits
24
css_N_RZwuHqJRq9K0jNDF0nvDdTfmFpGeXvIiao7I3RbLY.css
investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/
268 KB
41 KB
Stylesheet
General
Full URL
https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/css_N_RZwuHqJRq9K0jNDF0nvDdTfmFpGeXvIiao7I3RbLY.css?delta=3&language=en&theme=nir_pid3975&include=eJyVkmtOwzAMxy-0tRIIIc7BAaI8vNY0tYfjbhqnx32ItduQQP2Q-Od__YoJxcUOEiqLS17tCxlKfb3uyCS9lw50EriQOXZ1D56cQOS-BzKOTC62XvQXvSefL0WdmJQaF7z8Q17cVMsuskCdZDj6_A46edasOgo3AmWpeciKvbXm6625KxYZ-jr4ApNyvNQFk1yt8YKRaYn_8TmAXKoBqyMXHJu95RY3czPTnhMI4ZdsilMeYgsnIC17haKbCExxXQtkiPpUZQzi5XLnuAJTzHGQ1HJamoEseRnZjSP42AUm2ClztvnXy1nZAw530JPi_pDRlkNundsxreERn99eX-qY0dpckzOmBqzxsd4Zp4nzCUQwwQbOv-9b8NbKI8-BWW88vyWweSeepWcI9nbgiBWj7fgDVi3npJ920MxZ-WNVPnEAl_1Asf2D0JYyfQMmlE9n
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93b0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
0f80679cf2ce45ece8a99ec5a49920c2b74ad9324143065ff2c6b61b89f18fd5
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Expires
Sun, 02 Jun 2024 08:47:02 GMT
X-EdgeConnect-Origin-MEX-Latency
96
Date
Sun, 02 Jun 2024 08:44:12 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
X-EdgeConnect-MidMile-RTT
26
X-Age
51857
Connection
keep-alive
Content-Length
41888
X-Request-ID
v-f127ce7c-01a9-11ef-9a3d-3b771d0625fb
Last-Modified
Sat, 13 Apr 2024 09:50:56 GMT
Vary
Accept-Encoding
Content-Type
text/css
Cache-Control
max-age=170
Accept-Ranges
bytes
X-Cache-Hits
19
all.css
use.fontawesome.com/releases/v5.12.1/css/
56 KB
13 KB
Stylesheet
General
Full URL
https://use.fontawesome.com/releases/v5.12.1/css/all.css
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3037::ac43:8ef5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
9a680b90260b5106d79f4075491ab31daafa7429eff686453c40b58357309649

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 08:44:12 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Fri, 22 Sep 2023 01:45:05 GMT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
age
818441
etag
W/"2a0e11a7655cf7af50d9152727c134ef"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=q4sMafMw3O5rO7Xfi3le7R7Nr01AD%2FoBFUY%2Fwgo0JkV5UpMx7nT7x7Cf2eJQsoV7dv2BSeC2zugAufbPLJmGqyxyLm30DFqgy5sBIU6rGMAaNhj9hUYuUSeKBfpfMZ41sW4Z1n0nbYKdVys0V2hbbe1A"}],"group":"cf-nel","max_age":604800}
content-type
text/css
cache-control
max-age=31556926
cf-ray
88d629023ab3199e-FRA
alt-svc
h3=":443"; ma=86400
css_2m-JtTEkggMgnkTnz1Mc9S_LSZ3N3AvzItCbN_GaZMs.css
investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/
550 KB
76 KB
Stylesheet
General
Full URL
https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/css_2m-JtTEkggMgnkTnz1Mc9S_LSZ3N3AvzItCbN_GaZMs.css?delta=5&language=en&theme=nir_pid3975&include=eJyVkmtOwzAMxy-0tRIIIc7BAaI8vNY0tYfjbhqnx32ItduQQP2Q-Od__YoJxcUOEiqLS17tCxlKfb3uyCS9lw50EriQOXZ1D56cQOS-BzKOTC62XvQXvSefL0WdmJQaF7z8Q17cVMsuskCdZDj6_A46edasOgo3AmWpeciKvbXm6625KxYZ-jr4ApNyvNQFk1yt8YKRaYn_8TmAXKoBqyMXHJu95RY3czPTnhMI4ZdsilMeYgsnIC17haKbCExxXQtkiPpUZQzi5XLnuAJTzHGQ1HJamoEseRnZjSP42AUm2ClztvnXy1nZAw530JPi_pDRlkNundsxreERn99eX-qY0dpckzOmBqzxsd4Zp4nzCUQwwQbOv-9b8NbKI8-BWW88vyWweSeepWcI9nbgiBWj7fgDVi3npJ920MxZ-WNVPnEAl_1Asf2D0JYyfQMmlE9n
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93b0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
fca88fa766f57b983b0134b6f1a5531e4a2deb830bbf836b7cbc21362ad8ae37
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Expires
Sun, 02 Jun 2024 08:46:59 GMT
X-EdgeConnect-Origin-MEX-Latency
93
Date
Sun, 02 Jun 2024 08:44:12 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
X-EdgeConnect-MidMile-RTT
7
X-Age
51857
Connection
keep-alive
Content-Length
77050
X-Request-ID
v-f125cc44-01a9-11ef-a8b9-133993545445
Last-Modified
Sat, 13 Apr 2024 09:50:55 GMT
Vary
Accept-Encoding
Content-Type
text/css
Cache-Control
max-age=167
Accept-Ranges
bytes
X-Cache-Hits
25
v4-shims.css
use.fontawesome.com/releases/v5.12.1/css/
26 KB
4 KB
Stylesheet
General
Full URL
https://use.fontawesome.com/releases/v5.12.1/css/v4-shims.css
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3037::ac43:8ef5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
c198d1e767f39e0d69247c31e1a57600edf2c93397adc0d6ee306926d4f0571c

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 08:44:12 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Fri, 22 Sep 2023 01:45:05 GMT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
age
818423
etag
W/"6fe7c40e87191b9412c88e67a9a7e29d"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=1kLisihRP1POnfjCZNYMDqo3RRuMw%2FVOiPvAsthKvShg8miCtpvARPqMkS8ix87XL9AIlgb0YGaCi2aTMvJUHc95LfpsVpoa3zH4n8j7YIT23OB6NcTWVcqVkLAHb3oiYx8n7ifjGjUYTqTuZezTqfUI"}],"group":"cf-nel","max_age":604800}
content-type
text/css
cache-control
max-age=31556926
cf-ray
88d629023ab8199e-FRA
alt-svc
h3=":443"; ma=86400
css_HXl6rexFTGxxxNQnRkEWNmNjau0Ds0briwvWm1vopIY.css
investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/
59 KB
13 KB
Stylesheet
General
Full URL
https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/css_HXl6rexFTGxxxNQnRkEWNmNjau0Ds0briwvWm1vopIY.css?delta=7&language=en&theme=nir_pid3975&include=eJyVkmtOwzAMxy-0tRIIIc7BAaI8vNY0tYfjbhqnx32ItduQQP2Q-Od__YoJxcUOEiqLS17tCxlKfb3uyCS9lw50EriQOXZ1D56cQOS-BzKOTC62XvQXvSefL0WdmJQaF7z8Q17cVMsuskCdZDj6_A46edasOgo3AmWpeciKvbXm6625KxYZ-jr4ApNyvNQFk1yt8YKRaYn_8TmAXKoBqyMXHJu95RY3czPTnhMI4ZdsilMeYgsnIC17haKbCExxXQtkiPpUZQzi5XLnuAJTzHGQ1HJamoEseRnZjSP42AUm2ClztvnXy1nZAw530JPi_pDRlkNundsxreERn99eX-qY0dpckzOmBqzxsd4Zp4nzCUQwwQbOv-9b8NbKI8-BWW88vyWweSeepWcI9nbgiBWj7fgDVi3npJ920MxZ-WNVPnEAl_1Asf2D0JYyfQMmlE9n
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93b0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
3e02750193c87827348b8da65a3f08b457cac111a0b75b38a15f1bee14c6870d
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Expires
Sun, 02 Jun 2024 08:47:12 GMT
X-EdgeConnect-Origin-MEX-Latency
88
Date
Sun, 02 Jun 2024 08:44:12 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
X-EdgeConnect-MidMile-RTT
23
X-Age
51857
Connection
keep-alive
Content-Length
12769
X-Request-ID
v-f11d6e46-01a9-11ef-8e1b-ff2b49b9107d
Last-Modified
Sat, 13 Apr 2024 09:50:55 GMT
Vary
Accept-Encoding
Content-Type
text/css
Cache-Control
max-age=180
Accept-Ranges
bytes
X-Cache-Hits
28
css
fonts.googleapis.com/
21 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:100,300,regular,500,700|Work+Sans:100,200,300,regular,500,600,700,800,900
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
f4b3d3e2cfd639ff26132acff614fc07211c8332c1825a17ab0120b3159ee8b9
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

strict-transport-security
max-age=31536000
date
Sun, 02 Jun 2024 08:44:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Sun, 02 Jun 2024 08:44:12 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Sun, 02 Jun 2024 08:44:12 GMT
css
fonts.googleapis.com/
2 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Source+Sans+Pro&
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
55be8b195b7c6725b1bdc62b22af9f95f2ed7f2dd160a6e3d7ac0177add6e2f9
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

strict-transport-security
max-age=31536000
date
Sun, 02 Jun 2024 08:44:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Sun, 02 Jun 2024 07:09:31 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Sun, 02 Jun 2024 08:44:12 GMT
css
fonts.googleapis.com/
46 KB
2 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:100,100italic,200,200italic,300,300italic,400,400italic,500,500italic,600,600italic,700,700italic,800,800italic,900,900italic%7CWork+Sans:100,100italic,200,200italic,300,300italic,400,400italic,500,500italic,600,600italic,700,700italic,800,800italic,900,900italic&
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
1d099ba136eb7c4e065d17121ae1c27bf5e73d85a03407c38aa7ce5317084273
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

strict-transport-security
max-age=31536000
date
Sun, 02 Jun 2024 08:44:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Sun, 02 Jun 2024 08:44:12 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Sun, 02 Jun 2024 08:44:12 GMT
css_aaQ5MNnM42Op019id_qkMGMTTQ2wn54Xptlm4nOH1L0.css
investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/
168 KB
23 KB
Stylesheet
General
Full URL
https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/css_aaQ5MNnM42Op019id_qkMGMTTQ2wn54Xptlm4nOH1L0.css?delta=11&language=en&theme=nir_pid3975&include=eJyVkmtOwzAMxy-0tRIIIc7BAaI8vNY0tYfjbhqnx32ItduQQP2Q-Od__YoJxcUOEiqLS17tCxlKfb3uyCS9lw50EriQOXZ1D56cQOS-BzKOTC62XvQXvSefL0WdmJQaF7z8Q17cVMsuskCdZDj6_A46edasOgo3AmWpeciKvbXm6625KxYZ-jr4ApNyvNQFk1yt8YKRaYn_8TmAXKoBqyMXHJu95RY3czPTnhMI4ZdsilMeYgsnIC17haKbCExxXQtkiPpUZQzi5XLnuAJTzHGQ1HJamoEseRnZjSP42AUm2ClztvnXy1nZAw530JPi_pDRlkNundsxreERn99eX-qY0dpckzOmBqzxsd4Zp4nzCUQwwQbOv-9b8NbKI8-BWW88vyWweSeepWcI9nbgiBWj7fgDVi3npJ920MxZ-WNVPnEAl_1Asf2D0JYyfQMmlE9n
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93b0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
bbb9163057088e27efb5e78ab376211947225842822e7c35beeae5a09b660844
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Expires
Sun, 02 Jun 2024 08:47:11 GMT
X-EdgeConnect-Origin-MEX-Latency
89
Date
Sun, 02 Jun 2024 08:44:12 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
X-EdgeConnect-MidMile-RTT
54
X-Age
49871
Connection
keep-alive
Content-Length
23194
X-Request-ID
v-909585d6-01ae-11ef-8bb5-e7bc13f509f3
Last-Modified
Sat, 13 Apr 2024 09:50:55 GMT
Vary
Accept-Encoding
Content-Type
text/css
Cache-Control
max-age=179
Accept-Ranges
bytes
X-Cache-Hits
20
modernizr.min.js
investors.connectbiopharm.com/core/assets/vendor/modernizr/
7 KB
4 KB
Script
General
Full URL
https://investors.connectbiopharm.com/core/assets/vendor/modernizr/modernizr.min.js?v=3.11.7
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93b0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
939fe220ac3999512e38ecd5397d7334210c1568e7aec55eb6c6f4d1316c8353
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Expires
Sun, 02 Jun 2024 08:46:56 GMT
X-EdgeConnect-Origin-MEX-Latency
92
Date
Sun, 02 Jun 2024 08:44:12 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
X-EdgeConnect-MidMile-RTT
7
X-Age
473010
Connection
keep-alive
Content-Length
3090
X-Request-ID
v-bf21f4fc-1a4a-11ef-bcd0-6fc5c3117a1f
Last-Modified
Sat, 13 Jan 2024 02:45:13 GMT
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
max-age=164
Accept-Ranges
bytes
X-Cache-Hits
2487
js_7ThKeh1ra5zJdIlm-qhMOlvW6Zo3poudDmDYt5FVfSo.js
investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/js/
5 KB
2 KB
Script
General
Full URL
https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/js/js_7ThKeh1ra5zJdIlm-qhMOlvW6Zo3poudDmDYt5FVfSo.js?scope=header&delta=1&language=en&theme=nir_pid3975&include=eJyVkmtOwzAMxy-0tRIIIc7BAaI8vNY0tYfjbhqnx32ItduQQP2Q-Od__YoJxcUOEiqLS17tCxlKfb3uyCS9lw50EriQOXZ1D56cQOS-BzKOTC62XvQXvSefL0WdmJQaF7z8Q17cVMsuskCdZDj6_A46edasOgo3AmWpeciKvbXm6625KxYZ-jr4ApNyvNQFk1yt8YKRaYn_8TmAXKoBqyMXHJu95RY3czPTnhMI4ZdsilMeYgsnIC17haKbCExxXQtkiPpUZQzi5XLnuAJTzHGQ1HJamoEseRnZjSP42AUm2ClztvnXy1nZAw530JPi_pDRlkNundsxreERn99eX-qY0dpckzOmBqzxsd4Zp4nzCUQwwQbOv-9b8NbKI8-BWW88vyWweSeepWcI9nbgiBWj7fgDVi3npJ920MxZ-WNVPnEAl_1Asf2D0JYyfQMmlE9n
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93b0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
923c2885f40188e5a79144b0069c98230ed43761f0659d2d42fa7280eaeca82c
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Expires
Sun, 02 Jun 2024 08:46:56 GMT
X-EdgeConnect-Origin-MEX-Latency
95
Date
Sun, 02 Jun 2024 08:44:12 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
X-EdgeConnect-MidMile-RTT
7
X-Age
772700
Connection
keep-alive
Content-Length
1895
X-Request-ID
v-7e10eff4-01ae-11ef-b463-bb3517ce04e9
Last-Modified
Sat, 13 Apr 2024 09:50:55 GMT
Vary
Accept-Encoding
Content-Type
text/javascript
Cache-Control
max-age=164
Accept-Ranges
bytes
X-Cache-Hits
1123
js
www.googletagmanager.com/gtag/
267 KB
93 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-2BTFV1CHSX
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82f::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
ea0125a0219365788e53133ab052e43d278909e14d85ea9f5d437c97a55d4805
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 08:44:13 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
94832
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Sun, 02 Jun 2024 08:44:13 GMT
64a0fe51
investors.connectbiopharm.com/akam/13/
26 KB
10 KB
Script
General
Full URL
https://investors.connectbiopharm.com/akam/13/64a0fe51
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93b0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
d2ec33473be781d6c9dd2901034a4b6d7a488b2181da2bd0f990941f156117b4

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Pragma
no-cache
Date
Sun, 02 Jun 2024 08:44:13 GMT
Content-Encoding
gzip
Last-Modified
Thu, 22 Feb 2024 19:50:37 GMT
ETag
"8a9f4ba5a632aca8564b721d95fa2aeb34bab85051203dec4dde8930249324ac"
Stored-Attribute-Sha-Checksum
d2ec33473be781d6c9dd2901034a4b6d7a488b2181da2bd0f990941f156117b4
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
max-age=21600
Connection
keep-alive
Content-Length
8791
Expires
Sun, 02 Jun 2024 08:44:13 GMT
logo-color.svg
investors.connectbiopharm.com/sites/g/files/knoqqb83566/themes/site/nir_pid3975/client/wp-content/uploads/
5 KB
3 KB
Image
General
Full URL
https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/themes/site/nir_pid3975/client/wp-content/uploads/logo-color.svg
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93b0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
dca30ca42f8149a4728e5c42ac836c1d774b2a6305a547316144b0e4fc8ae888
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Expires
Sun, 02 Jun 2024 08:44:42 GMT
X-EdgeConnect-Origin-MEX-Latency
97, 97, 98, 94, 94
Date
Sun, 02 Jun 2024 08:44:12 GMT
X-DataStream-Origin-MEX-Latency
97
X-Content-Type-Options
nosniff
Content-Encoding
gzip
X-DataStream-MidMile-RTT
0
X-EdgeConnect-MidMile-RTT
0, 0, 0, 0, 10
X-Age
17921
Connection
keep-alive
Content-Length
2055
X-Request-ID
v-c710d6f2-c806-11ed-a503-7334fe64cb39
Last-Modified
Fri, 17 Mar 2023 18:10:10 GMT
Vary
Accept-Encoding
Content-Type
image/svg+xml
Cache-Control
max-age=30
Accept-Ranges
bytes
X-DataStream-Cache-Status
3
X-Cache-Hits
95
css_Zy9SwllLIoSLJnKpgSA7XpI2LwK1IvMvaSq_fmQF3AY.css
investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/
3 KB
1 KB
Stylesheet
General
Full URL
https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/css_Zy9SwllLIoSLJnKpgSA7XpI2LwK1IvMvaSq_fmQF3AY.css?delta=2&language=en&theme=nir_pid3975&include=eJyVkmtOwzAMxy-0tRIIIc7BAaI8vNY0tYfjbhqnx32ItduQQP2Q-Od__YoJxcUOEiqLS17tCxlKfb3uyCS9lw50EriQOXZ1D56cQOS-BzKOTC62XvQXvSefL0WdmJQaF7z8Q17cVMsuskCdZDj6_A46edasOgo3AmWpeciKvbXm6625KxYZ-jr4ApNyvNQFk1yt8YKRaYn_8TmAXKoBqyMXHJu95RY3czPTnhMI4ZdsilMeYgsnIC17haKbCExxXQtkiPpUZQzi5XLnuAJTzHGQ1HJamoEseRnZjSP42AUm2ClztvnXy1nZAw530JPi_pDRlkNundsxreERn99eX-qY0dpckzOmBqzxsd4Zp4nzCUQwwQbOv-9b8NbKI8-BWW88vyWweSeepWcI9nbgiBWj7fgDVi3npJ920MxZ-WNVPnEAl_1Asf2D0JYyfQMmlE9n
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93b0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
362f77cce3f38b14048c337dcab0fd1a52158314cae93cc9520a9888d0c967ec
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Expires
Sun, 02 Jun 2024 08:46:59 GMT
X-EdgeConnect-Origin-MEX-Latency
93
Date
Sun, 02 Jun 2024 08:44:13 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
X-EdgeConnect-MidMile-RTT
9
X-Age
51857
Connection
keep-alive
Content-Length
868
X-Request-ID
v-f1206e84-01a9-11ef-a834-57d9e5523453
Last-Modified
Sat, 13 Apr 2024 09:50:57 GMT
Vary
Accept-Encoding
Content-Type
text/css
Cache-Control
max-age=166
Accept-Ranges
bytes
X-Cache-Hits
23
Connect-Biopharma-Holdings-Lim.png
ml.globenewswire.com/media/YzJhNWUzNDAtM2I2Mi00YzMxLWIzMzQtYzNjOTRkMGUzODg0LTEyMTkwNjQ=/tiny/
35 B
234 B
Image
General
Full URL
https://ml.globenewswire.com/media/YzJhNWUzNDAtM2I2Mi00YzMxLWIzMzQtYzNjOTRkMGUzODg0LTEyMTkwNjQ=/tiny/Connect-Biopharma-Holdings-Lim.png
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93c0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options ALLOWALL
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Sun, 02 Jun 2024 08:44:12 GMT
x-content-type-options
nosniff
x-frame-options
ALLOWALL
content-type
image/png
cache-control
no-cache, no-store, must-revalidate
content-length
35
x-xss-protection
1; mode=block
expires
Sun, 02 Jun 2024 08:44:12 GMT
js_iKZ_wA6wamDFIPceQWfMUCuvtEXn34ZCEbEzjUa-v4Q.js
investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/js/
1 MB
381 KB
Script
General
Full URL
https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/js/js_iKZ_wA6wamDFIPceQWfMUCuvtEXn34ZCEbEzjUa-v4Q.js?scope=footer&delta=0&language=en&theme=nir_pid3975&include=eJyVkmtOwzAMxy-0tRIIIc7BAaI8vNY0tYfjbhqnx32ItduQQP2Q-Od__YoJxcUOEiqLS17tCxlKfb3uyCS9lw50EriQOXZ1D56cQOS-BzKOTC62XvQXvSefL0WdmJQaF7z8Q17cVMsuskCdZDj6_A46edasOgo3AmWpeciKvbXm6625KxYZ-jr4ApNyvNQFk1yt8YKRaYn_8TmAXKoBqyMXHJu95RY3czPTnhMI4ZdsilMeYgsnIC17haKbCExxXQtkiPpUZQzi5XLnuAJTzHGQ1HJamoEseRnZjSP42AUm2ClztvnXy1nZAw530JPi_pDRlkNundsxreERn99eX-qY0dpckzOmBqzxsd4Zp4nzCUQwwQbOv-9b8NbKI8-BWW88vyWweSeepWcI9nbgiBWj7fgDVi3npJ920MxZ-WNVPnEAl_1Asf2D0JYyfQMmlE9n
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93b0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
adfe2417f6ffed73110ca384ee98bdc50385ce7c08a8b225860e768e17908248
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Expires
Sun, 02 Jun 2024 08:47:13 GMT
X-EdgeConnect-Origin-MEX-Latency
94
Date
Sun, 02 Jun 2024 08:44:13 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
X-EdgeConnect-MidMile-RTT
7
X-Age
49902
Connection
keep-alive
Content-Length
389297
X-Request-ID
v-7e0d07ae-01ae-11ef-a54b-9fd759a7aca3
Last-Modified
Sat, 13 Apr 2024 09:51:05 GMT
Vary
Accept-Encoding
Content-Type
text/javascript
Cache-Control
max-age=180
Accept-Ranges
bytes
X-Cache-Hits
18
launch-5ef258dce664.min.js
assets.adobedtm.com/898335afd880/c52ee8aa1e90/
163 KB
50 KB
Script
General
Full URL
https://assets.adobedtm.com/898335afd880/c52ee8aa1e90/launch-5ef258dce664.min.js
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:3500:591::1e80 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
3777c25911c0259e059287354a170a0046dabc074b075d6e5ff47045f7a51492

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 08:44:13 GMT
content-encoding
gzip
last-modified
Fri, 03 Feb 2023 18:00:37 GMT
server
AkamaiNetStorage
etag
"48246fd3c5f42a4da830ac25312a135f:1675447237.500488"
vary
Accept-Encoding
content-type
application/x-javascript
access-control-allow-origin
https://investors.connectbiopharm.com
cache-control
max-age=3600
accept-ranges
bytes
timing-allow-origin
*
content-length
50604
expires
Sun, 02 Jun 2024 09:44:13 GMT
KFOlCnqEu92Fr1MmSU5fBBc4.woff2
fonts.gstatic.com/s/roboto/v30/
15 KB
15 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmSU5fBBc4.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:100,300,regular,500,700|Work+Sans:100,200,300,regular,500,600,700,800,900
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:810::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f75911313e1c7802c23345ab57e754d87801581706780c993fb23ff4e0fe62ef
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://fonts.googleapis.com/
Origin
https://investors.connectbiopharm.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sat, 01 Jun 2024 13:29:52 GMT
x-content-type-options
nosniff
age
69261
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15740
x-xss-protection
0
last-modified
Wed, 11 May 2022 19:24:56 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 01 Jun 2025 13:29:52 GMT
pageheaders_9.jpg
www.connectbiopharm.com/wp-content/uploads/
141 KB
141 KB
Image
General
Full URL
https://www.connectbiopharm.com/wp-content/uploads/pageheaders_9.jpg
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/css_N_RZwuHqJRq9K0jNDF0nvDdTfmFpGeXvIiao7I3RbLY.css?delta=3&language=en&theme=nir_pid3975&include=eJyVkmtOwzAMxy-0tRIIIc7BAaI8vNY0tYfjbhqnx32ItduQQP2Q-Od__YoJxcUOEiqLS17tCxlKfb3uyCS9lw50EriQOXZ1D56cQOS-BzKOTC62XvQXvSefL0WdmJQaF7z8Q17cVMsuskCdZDj6_A46edasOgo3AmWpeciKvbXm6625KxYZ-jr4ApNyvNQFk1yt8YKRaYn_8TmAXKoBqyMXHJu95RY3czPTnhMI4ZdsilMeYgsnIC17haKbCExxXQtkiPpUZQzi5XLnuAJTzHGQ1HJamoEseRnZjSP42AUm2ClztvnXy1nZAw530JPi_pDRlkNundsxreERn99eX-qY0dpckzOmBqzxsd4Zp4nzCUQwwQbOv-9b8NbKI8-BWW88vyWweSeepWcI9nbgiBWj7fgDVi3npJ920MxZ-WNVPnEAl_1Asf2D0JYyfQMmlE9n
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
35.190.31.54 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
54.31.190.35.bc.googleusercontent.com
Software
nginx /
Resource Hash
d2744abdbf498b0b715f0ff0b47f610b6198598330312169ad19bd9e32a7d75c

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

x-proxy-cache
HIT
date
Sun, 02 Jun 2024 08:44:13 GMT
expires
Mon, 02 Jun 2025 03:10:02 GMT
last-modified
Wed, 27 Jan 2021 15:09:55 GMT
server
nginx
etag
"60118243-2327d"
content-type
image/jpeg
cache-control
max-age=31536000
host-header
8441280b0c35cbc1147f8ba998a563a7
accept-ranges
bytes
content-length
143997
x-cdn-c
static
x-sg-cdn
1
KFOmCnqEu92Fr1Mu4mxK.woff2
fonts.gstatic.com/s/roboto/v30/
15 KB
15 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v30/KFOmCnqEu92Fr1Mu4mxK.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:100,300,regular,500,700|Work+Sans:100,200,300,regular,500,600,700,800,900
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:810::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f6734f8177112c0839b961f96d813fcb189d81b60e96c33278c1983b6f419615
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://fonts.googleapis.com/
Origin
https://investors.connectbiopharm.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sat, 01 Jun 2024 08:44:47 GMT
x-content-type-options
nosniff
age
86366
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15744
x-xss-protection
0
last-modified
Wed, 11 May 2022 19:24:48 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 01 Jun 2025 08:44:47 GMT
QGYsz_wNahGAdqQ43Rh_fKDp.woff2
fonts.gstatic.com/s/worksans/v19/
49 KB
50 KB
Font
General
Full URL
https://fonts.gstatic.com/s/worksans/v19/QGYsz_wNahGAdqQ43Rh_fKDp.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:100,300,regular,500,700|Work+Sans:100,200,300,regular,500,600,700,800,900
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:810::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
6912f7388531e949bd5406b5668cd6b55fea4cc7e2d123dbaed489054dd98438
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://fonts.googleapis.com/
Origin
https://investors.connectbiopharm.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sat, 01 Jun 2024 06:00:57 GMT
x-content-type-options
nosniff
age
96196
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
50668
x-xss-protection
0
last-modified
Thu, 14 Sep 2023 01:13:52 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 01 Jun 2025 06:00:57 GMT
KFOlCnqEu92Fr1MmWUlfBBc4.woff2
fonts.gstatic.com/s/roboto/v30/
15 KB
16 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmWUlfBBc4.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:100,300,regular,500,700|Work+Sans:100,200,300,regular,500,600,700,800,900
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:810::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f5aebdfea35d1e7656ef4acc5db1f243209755ae3300943ef8fc6280f363c860
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://fonts.googleapis.com/
Origin
https://investors.connectbiopharm.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sat, 01 Jun 2024 00:45:23 GMT
x-content-type-options
nosniff
age
115130
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15860
x-xss-protection
0
last-modified
Wed, 11 May 2022 19:24:42 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 01 Jun 2025 00:45:23 GMT
ndqfonticons.woff
investors.connectbiopharm.com/sites/g/files/knoqqb83566/themes/site/nir_pid3975/fonts/
26 KB
26 KB
Font
General
Full URL
https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/themes/site/nir_pid3975/fonts/ndqfonticons.woff
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/css_N_RZwuHqJRq9K0jNDF0nvDdTfmFpGeXvIiao7I3RbLY.css?delta=3&language=en&theme=nir_pid3975&include=eJyVkmtOwzAMxy-0tRIIIc7BAaI8vNY0tYfjbhqnx32ItduQQP2Q-Od__YoJxcUOEiqLS17tCxlKfb3uyCS9lw50EriQOXZ1D56cQOS-BzKOTC62XvQXvSefL0WdmJQaF7z8Q17cVMsuskCdZDj6_A46edasOgo3AmWpeciKvbXm6625KxYZ-jr4ApNyvNQFk1yt8YKRaYn_8TmAXKoBqyMXHJu95RY3czPTnhMI4ZdsilMeYgsnIC17haKbCExxXQtkiPpUZQzi5XLnuAJTzHGQ1HJamoEseRnZjSP42AUm2ClztvnXy1nZAw530JPi_pDRlkNundsxreERn99eX-qY0dpckzOmBqzxsd4Zp4nzCUQwwQbOv-9b8NbKI8-BWW88vyWweSeepWcI9nbgiBWj7fgDVi3npJ920MxZ-WNVPnEAl_1Asf2D0JYyfQMmlE9n
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93b0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
c373e792c789d8e45fa8fd623dcac7e06eb7bbb78bd44439ced7bc0f6d5e025b
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/css_N_RZwuHqJRq9K0jNDF0nvDdTfmFpGeXvIiao7I3RbLY.css?delta=3&language=en&theme=nir_pid3975&include=eJyVkmtOwzAMxy-0tRIIIc7BAaI8vNY0tYfjbhqnx32ItduQQP2Q-Od__YoJxcUOEiqLS17tCxlKfb3uyCS9lw50EriQOXZ1D56cQOS-BzKOTC62XvQXvSefL0WdmJQaF7z8Q17cVMsuskCdZDj6_A46edasOgo3AmWpeciKvbXm6625KxYZ-jr4ApNyvNQFk1yt8YKRaYn_8TmAXKoBqyMXHJu95RY3czPTnhMI4ZdsilMeYgsnIC17haKbCExxXQtkiPpUZQzi5XLnuAJTzHGQ1HJamoEseRnZjSP42AUm2ClztvnXy1nZAw530JPi_pDRlkNundsxreERn99eX-qY0dpckzOmBqzxsd4Zp4nzCUQwwQbOv-9b8NbKI8-BWW88vyWweSeepWcI9nbgiBWj7fgDVi3npJ920MxZ-WNVPnEAl_1Asf2D0JYyfQMmlE9n
Origin
https://investors.connectbiopharm.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Expires
Sun, 02 Jun 2024 08:44:43 GMT
X-EdgeConnect-Origin-MEX-Latency
97, 98, 92, 92
Date
Sun, 02 Jun 2024 08:44:13 GMT
X-DataStream-Origin-MEX-Latency
97
X-Content-Type-Options
nosniff
X-DataStream-MidMile-RTT
0
X-EdgeConnect-MidMile-RTT
0, 0, 0, 7
X-Age
173770
Connection
keep-alive
Content-Length
26304
X-Request-ID
v-efd53df4-c805-11ed-bf9d-03e83e65b146
Last-Modified
Fri, 17 Mar 2023 18:10:10 GMT
Cache-Control
max-age=30
Accept-Ranges
bytes
X-DataStream-Cache-Status
3
X-Cache-Hits
112
KFOjCnqEu92Fr1Mu51TzBic6CsQ.woff2
fonts.gstatic.com/s/roboto/v30/
17 KB
17 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v30/KFOjCnqEu92Fr1Mu51TzBic6CsQ.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:100,100italic,200,200italic,300,300italic,400,400italic,500,500italic,600,600italic,700,700italic,800,800italic,900,900italic%7CWork+Sans:100,100italic,200,200italic,300,300italic,400,400italic,500,500italic,600,600italic,700,700italic,800,800italic,900,900italic&#038;ver=5.6.1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:810::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
6be97ca17228a69c406231d89c003194c3dfba7401eaa9fe9e9ed0ef1c18dc38
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://fonts.googleapis.com/
Origin
https://investors.connectbiopharm.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 13:02:14 GMT
x-content-type-options
nosniff
age
416519
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
17032
x-xss-protection
0
last-modified
Wed, 11 May 2022 19:24:52 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 28 May 2025 13:02:14 GMT
generatepress.woff2
investors.connectbiopharm.com/sites/g/files/knoqqb83566/themes/site/nir_pid3975/client/wp-content/themes/generatepress/fonts/
1 KB
2 KB
Font
General
Full URL
https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/themes/site/nir_pid3975/client/wp-content/themes/generatepress/fonts/generatepress.woff2
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/css_N_RZwuHqJRq9K0jNDF0nvDdTfmFpGeXvIiao7I3RbLY.css?delta=3&language=en&theme=nir_pid3975&include=eJyVkmtOwzAMxy-0tRIIIc7BAaI8vNY0tYfjbhqnx32ItduQQP2Q-Od__YoJxcUOEiqLS17tCxlKfb3uyCS9lw50EriQOXZ1D56cQOS-BzKOTC62XvQXvSefL0WdmJQaF7z8Q17cVMsuskCdZDj6_A46edasOgo3AmWpeciKvbXm6625KxYZ-jr4ApNyvNQFk1yt8YKRaYn_8TmAXKoBqyMXHJu95RY3czPTnhMI4ZdsilMeYgsnIC17haKbCExxXQtkiPpUZQzi5XLnuAJTzHGQ1HJamoEseRnZjSP42AUm2ClztvnXy1nZAw530JPi_pDRlkNundsxreERn99eX-qY0dpckzOmBqzxsd4Zp4nzCUQwwQbOv-9b8NbKI8-BWW88vyWweSeepWcI9nbgiBWj7fgDVi3npJ920MxZ-WNVPnEAl_1Asf2D0JYyfQMmlE9n
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93b0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
51514868480542bf1fff9447036b143140b651ee4ad61f6025ce47bb918e84cf
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/css/css_N_RZwuHqJRq9K0jNDF0nvDdTfmFpGeXvIiao7I3RbLY.css?delta=3&language=en&theme=nir_pid3975&include=eJyVkmtOwzAMxy-0tRIIIc7BAaI8vNY0tYfjbhqnx32ItduQQP2Q-Od__YoJxcUOEiqLS17tCxlKfb3uyCS9lw50EriQOXZ1D56cQOS-BzKOTC62XvQXvSefL0WdmJQaF7z8Q17cVMsuskCdZDj6_A46edasOgo3AmWpeciKvbXm6625KxYZ-jr4ApNyvNQFk1yt8YKRaYn_8TmAXKoBqyMXHJu95RY3czPTnhMI4ZdsilMeYgsnIC17haKbCExxXQtkiPpUZQzi5XLnuAJTzHGQ1HJamoEseRnZjSP42AUm2ClztvnXy1nZAw530JPi_pDRlkNundsxreERn99eX-qY0dpckzOmBqzxsd4Zp4nzCUQwwQbOv-9b8NbKI8-BWW88vyWweSeepWcI9nbgiBWj7fgDVi3npJ920MxZ-WNVPnEAl_1Asf2D0JYyfQMmlE9n
Origin
https://investors.connectbiopharm.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Expires
Sun, 02 Jun 2024 08:44:42 GMT
X-EdgeConnect-Origin-MEX-Latency
96, 97, 98, 94, 90, 88
Date
Sun, 02 Jun 2024 08:44:13 GMT
X-DataStream-Origin-MEX-Latency
97
X-Content-Type-Options
nosniff
X-DataStream-MidMile-RTT
0
X-EdgeConnect-MidMile-RTT
1, 0, 0, 0, 0, 50
X-Age
134583
Connection
keep-alive
Content-Length
1264
X-Request-ID
v-e59ca41c-c805-11ed-b5e7-43044dbe0579
Last-Modified
Fri, 17 Mar 2023 18:10:10 GMT
Cache-Control
max-age=29
Accept-Ranges
bytes
X-DataStream-Cache-Status
3
X-Cache-Hits
94
KFOlCnqEu92Fr1MmSU5fBxc4EsA.woff2
fonts.gstatic.com/s/roboto/v30/
7 KB
7 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmSU5fBxc4EsA.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:100,300,regular,500,700|Work+Sans:100,200,300,regular,500,600,700,800,900
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:810::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
455c2c1af0a2bf20047a1864d7d7c174983407b58465cdb000b9c47565f9ee3b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://fonts.googleapis.com/
Origin
https://investors.connectbiopharm.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sat, 01 Jun 2024 02:48:38 GMT
x-content-type-options
nosniff
age
107735
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
7120
x-xss-protection
0
last-modified
Wed, 11 May 2022 19:24:55 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 01 Jun 2025 02:48:38 GMT
KFOjCnqEu92Fr1Mu51TjASc6CsQ.woff2
fonts.gstatic.com/s/roboto/v30/
17 KB
17 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v30/KFOjCnqEu92Fr1Mu51TjASc6CsQ.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:100,100italic,200,200italic,300,300italic,400,400italic,500,500italic,600,600italic,700,700italic,800,800italic,900,900italic%7CWork+Sans:100,100italic,200,200italic,300,300italic,400,400italic,500,500italic,600,600italic,700,700italic,800,800italic,900,900italic&#038;ver=5.6.1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:810::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
bb8007225d94a099cddbade7ea904667c0dd0b68d5e30778e5c6257589ab94d1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://fonts.googleapis.com/
Origin
https://investors.connectbiopharm.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 31 May 2024 21:43:43 GMT
x-content-type-options
nosniff
age
126030
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
17508
x-xss-protection
0
last-modified
Wed, 11 May 2022 19:24:41 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 31 May 2025 21:43:43 GMT
collect
region1.google-analytics.com/g/
0
263 B
Ping
General
Full URL
https://region1.google-analytics.com/g/collect?v=2&tid=G-2BTFV1CHSX&gtm=45je45t0v869043603za200&_p=1717317852902&gcd=13l3l3l2l1&npa=1&dma_cps=sypham&dma=1&cid=746833759.1717317853&ul=de-de&sr=1600x1200&uaa=x86&uab=64&uafvl=Google%2520Chrome%3B125.0.6422.112%7CChromium%3B125.0.6422.112%7CNot.A%252FBrand%3B24.0.0.0&uamb=0&uam=&uap=Win32&uapv=10.0.0&uaw=0&are=1&frm=0&pscdl=noapi&_s=1&sid=1717317853&sct=1&seg=0&dl=https%3A%2F%2Finvestors.connectbiopharm.com%2Fnews-releases%2Fnews-release-details%2Fconnect-biopharma-announces-positive-rademikibart-global-phase&dt=Connect%20Biopharma%20Announces%20Positive%20Rademikibart%20Global%20Phase%202b%20Topline%20Results%20in%20Adult%20Patients%20with%20Moderate-to-Severe%20Persistent%20Asthma%20%7C%20Connect%20Biopharma%20Holdings%20Ltd&en=page_view&_fv=1&_nsi=1&_ss=1&_ee=1&tfd=2120
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-2BTFV1CHSX
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4860:4802:34::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Sun, 02 Jun 2024 08:44:13 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://investors.connectbiopharm.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
wp-emoji-release.min.js
www.connectbiopharm.com/wp-includes/js/
18 KB
6 KB
Script
General
Full URL
https://www.connectbiopharm.com/wp-includes/js/wp-emoji-release.min.js?ver=5.6.1
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/js/js_iKZ_wA6wamDFIPceQWfMUCuvtEXn34ZCEbEzjUa-v4Q.js?scope=footer&delta=0&language=en&theme=nir_pid3975&include=eJyVkmtOwzAMxy-0tRIIIc7BAaI8vNY0tYfjbhqnx32ItduQQP2Q-Od__YoJxcUOEiqLS17tCxlKfb3uyCS9lw50EriQOXZ1D56cQOS-BzKOTC62XvQXvSefL0WdmJQaF7z8Q17cVMsuskCdZDj6_A46edasOgo3AmWpeciKvbXm6625KxYZ-jr4ApNyvNQFk1yt8YKRaYn_8TmAXKoBqyMXHJu95RY3czPTnhMI4ZdsilMeYgsnIC17haKbCExxXQtkiPpUZQzi5XLnuAJTzHGQ1HJamoEseRnZjSP42AUm2ClztvnXy1nZAw530JPi_pDRlkNundsxreERn99eX-qY0dpckzOmBqzxsd4Zp4nzCUQwwQbOv-9b8NbKI8-BWW88vyWweSeepWcI9nbgiBWj7fgDVi3npJ920MxZ-WNVPnEAl_1Asf2D0JYyfQMmlE9n
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
35.190.31.54 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
54.31.190.35.bc.googleusercontent.com
Software
nginx /
Resource Hash
4e6ce5444c7f396cef0eb1fa3611034151e485dd06fbe5573a5583e1eebc98c3

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

x-proxy-cache
MISS
date
Sun, 02 Jun 2024 08:44:14 GMT
content-encoding
gzip
expires
Mon, 02 Jun 2025 08:44:14 GMT
last-modified
Thu, 04 Apr 2024 03:23:28 GMT
server
nginx
etag
W/"660e1d30-4926"
vary
Accept-Encoding
x-proxy-cache-info
0 NC:000000 UP:
content-type
application/javascript
cache-control
max-age=31536000
host-header
8441280b0c35cbc1147f8ba998a563a7
x-cdn-c
static
x-sg-cdn
1
id
dpm.demdex.net/
185 B
675 B
XHR
General
Full URL
https://dpm.demdex.net/id?d_visid_ver=5.5.0&d_fieldgroup=MC&d_rtbd=json&d_ver=2&d_orgid=98CF678254E93B1B0A4C98A5%40AdobeOrg&d_nsid=0&d_coppa=true&ts=1717317853382
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/898335afd880/c52ee8aa1e90/launch-5ef258dce664.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.76.80.14 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-76-80-14.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
65cf9601882c826bb02bf8b5284759f70ce27d809be1a8077033f137e7e5edb2
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

dcs
dcs-prod-irl1-2-v061-0ae9b9fc0.edge-irl1.demdex.com 2 ms
pragma
no-cache
date
Sun, 02 Jun 2024 08:44:13 GMT
strict-transport-security
max-age=31536000; includeSubDomains
content-encoding
gzip
x-tid
zDdivJqpQPM=
vary
Origin
content-type
application/json;charset=utf-8
p3p
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
access-control-allow-origin
https://investors.connectbiopharm.com
cache-control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
access-control-allow-credentials
true
content-length
184
expires
Thu, 01 Jan 1970 00:00:00 UTC
EX9f1ce69e4b404891b885911666e7b92a-libraryCode_source.min.js
assets.adobedtm.com/898335afd880/c52ee8aa1e90/a9a9246fcf93/
36 KB
13 KB
Script
General
Full URL
https://assets.adobedtm.com/898335afd880/c52ee8aa1e90/a9a9246fcf93/EX9f1ce69e4b404891b885911666e7b92a-libraryCode_source.min.js
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/898335afd880/c52ee8aa1e90/launch-5ef258dce664.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:3500:591::1e80 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
f2d45bebe310e6913fb1846dd661fc9fad22185c8b06e499feae67726fc5ab17

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 08:44:13 GMT
content-encoding
gzip
last-modified
Fri, 03 Feb 2023 18:00:38 GMT
server
AkamaiNetStorage
etag
"fa4a382999ecbaa870ece29003fe5cd0:1675447238.121712"
vary
Accept-Encoding
content-type
application/x-javascript
access-control-allow-origin
https://investors.connectbiopharm.com
cache-control
max-age=3600
accept-ranges
bytes
timing-allow-origin
*
content-length
13535
expires
Sun, 02 Jun 2024 09:44:13 GMT
truncated
/
9 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
d554361630709572f4c9e33d02ca5ae56275756099a62195513017a0421f73c2

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Content-Type
image/png
truncated
/
157 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
80d54533f80e8233621f965ae0a7713928bdb4d491ed0eb5e90434550f1894cb

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Content-Type
image/png
s03657268755774
thomsonreuterscorporategroupweb.sc.omtrdc.net/b/ss/trcgsuzhouconnectbiopharmaceuticals,trcgclientwebglobal/1/JS-2.22.0-LCXS/
43 B
344 B
Image
General
Full URL
https://thomsonreuterscorporategroupweb.sc.omtrdc.net/b/ss/trcgsuzhouconnectbiopharmaceuticals,trcgclientwebglobal/1/JS-2.22.0-LCXS/s03657268755774?AQB=1&ndh=1&pf=1&t=2%2F5%2F2024%2010%3A44%3A13%200%20-120&mid=24604395002450466310463618449650533049&aamlh=6&ce=UTF-8&pageName=Connect%20Biopharma%20Announces%20Positive%20Rademikibart%20Global%20Phase%202b%20Topline%20Results%20in%20Adult%20Patients%20with%20Moderate-to-Severe%20Persistent%20Asthma%20%7C%20Connect%20Biopharma%20Holdings%20Ltd&g=https%3A%2F%2Finvestors.connectbiopharm.com%2Fnews-releases%2Fnews-release-details%2Fconnect-biopharma-announces-positive-rademikibart-global-phase&cc=USD&aamb=6G1ynYcLPuiQxYZrsz_pkqfLG9yMXBpb2zX5dvJdYQJzPXImdj0y&s=1600x1200&c=24&j=1.6&v=N&k=Y&bw=1600&bh=1200&mcorgid=98CF678254E93B1B0A4C98A5%40AdobeOrg&AQE=1
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
63.140.62.27 , United States, ASN15224 (OMNITURE, US),
Reverse DNS
ip-63-140-62-27.data.adobedc.net
Software
jag /
Resource Hash
a1ecbaed793a1f564c49c671f2dd0ce36f858534ef6d26b55783a06b884cc506
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Sun, 02 Jun 2024 08:44:13 GMT
x-content-type-options
nosniff
last-modified
Mon, 03 Jun 2024 08:44:13 GMT
server
jag
etag
3687912008161394688-4618571723943822176
vary
*
p3p
CP="This is not a P3P policy"
access-control-allow-origin
*
content-type
image/gif;charset=utf-8
cache-control
no-cache, no-store, max-age=0, no-transform, private
content-length
43
x-xss-protection
1; mode=block
expires
Sat, 01 Jun 2024 08:44:13 GMT
pixel_64a0fe51
investors.connectbiopharm.com/akam/13/
0
772 B
XHR
General
Full URL
https://investors.connectbiopharm.com/akam/13/pixel_64a0fe51
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/akam/13/64a0fe51
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93b0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

Date
Sun, 02 Jun 2024 08:44:13 GMT
Connection
keep-alive
Content-Length
0
Content-Type
text/html
nr-rum-1.260.1.min.js
js-agent.newrelic.com/
50 KB
17 KB
Script
General
Full URL
https://js-agent.newrelic.com/nr-rum-1.260.1.min.js
Requested by
Host: investors.connectbiopharm.com
URL: https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2602:816:5001::39 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
6da25b260ec64d32f9bbcc4ea288de2c7c8f10b937f0fa20e6d732c78ef01833
Security Headers
Name Value
Strict-Transport-Security max-age=300

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Origin
https://investors.connectbiopharm.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

x-amz-version-id
raocR3Uv2ABMSTXBpS9IrgeVUtOtDkTF
content-encoding
br
via
1.1 varnish
date
Sun, 02 Jun 2024 08:44:14 GMT
strict-transport-security
max-age=300
x-amz-request-id
W10222K93PW0432J
x-amz-server-side-encryption
AES256
x-cache
HIT
cross-origin-resource-policy
cross-origin
content-length
17413
x-amz-id-2
3BpxHzSp1GF42/ZytPwT+00xLlXn7D2zo6YUA8e/blOoGWv1x0R/sOW1JYpDOev5kr0NNLykalI=
x-served-by
cache-mxp6928-MXP
last-modified
Mon, 20 May 2024 17:44:48 GMT
server
AmazonS3
etag
"e08d93f66108e56e014e2871a4460ec9"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000, stale-while-revalidate=86400, stale-if-error=86400
accept-ranges
bytes
x-cache-hits
97252
favicons.png
investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/
503 B
1 KB
Other
General
Full URL
https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/favicons.png
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:e300::211:93b0 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
266edf79a87a0cf532e4151e2db5bee569e120330fa8dc47e6c4f101d2a474f0
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Expires
Sun, 02 Jun 2024 08:44:42 GMT
X-EdgeConnect-Origin-MEX-Latency
97, 98, 98, 92, 93, 89
Date
Sun, 02 Jun 2024 08:44:14 GMT
X-DataStream-Origin-MEX-Latency
98
X-Content-Type-Options
nosniff
X-DataStream-MidMile-RTT
0
X-EdgeConnect-MidMile-RTT
0, 0, 0, 0, 0, 22
X-Age
18300
Connection
keep-alive
Content-Length
503
X-Request-ID
v-e57070e0-c805-11ed-a975-abd3b2340d71
Last-Modified
Wed, 24 Feb 2021 12:03:11 GMT
Content-Type
image/png
Cache-Control
max-age=28
Accept-Ranges
bytes
X-DataStream-Cache-Status
3
X-Cache-Hits
108
761e715901
bam.nr-data.net/1/
148 B
623 B
XHR
General
Full URL
https://bam.nr-data.net/1/761e715901?a=32397309,24276188&v=1.260.1&to=ZlVXYRcAW0ZRW0QKX18fdFYRCFpbH3xCFkBQXGlbCgVQaXNXXhdCXlxZUBc9e1pUXWYKVUZzWlsRE1pZXF1CTg5HWVBC&rst=3350&ck=0&s=e3a4286446aaa5ed&ref=https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase&ptid=a9ba994b717fce04&qt=18&ap=258&be=1349&fe=1833&dc=1001&at=ShJUF18aSEg%3D&fsh=1&perf=%7B%22timing%22:%7B%22of%22:1717317851056,%22n%22:0,%22f%22:0,%22dn%22:61,%22dne%22:61,%22c%22:61,%22s%22:616,%22ce%22:797,%22rq%22:797,%22rp%22:1350,%22rpe%22:1389,%22di%22:2329,%22ds%22:2339,%22de%22:2350,%22dc%22:3179,%22l%22:3179,%22le%22:3182%7D,%22navigation%22:%7B%7D%7D&fp=1871&fcp=1871
Requested by
Host: js-agent.newrelic.com
URL: https://js-agent.newrelic.com/nr-rum-1.260.1.min.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
162.247.243.29 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
1d4f8ceda97d48782b2f1b12bd60a7a68f3e9950df43ed4b9865d973371fd871

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://investors.connectbiopharm.com/news-releases/news-release-details/connect-biopharma-announces-positive-rademikibart-global-phase
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Sun, 02 Jun 2024 08:44:14 GMT
access-control-allow-methods
GET, POST, PUT, HEAD, OPTIONS
content-type
text/plain
access-control-allow-origin
https://investors.connectbiopharm.com
access-control-expose-headers
Date
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
Connection
keep-alive
timing-allow-origin
https://investors.connectbiopharm.com
Content-Length
148
x-served-by
cache-fra-etou8220090-FRA

Verdicts & Comments Add Verdict or Comment

68 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| NREUM object| webpackChunk:NRBA-1.260.1.PROD object| newrelic object| Modernizr object| Wpfcll function| wpfci function| gtag object| dataLayer string| bazadebezolkohpepadr string| s_CCSWebHostingAccount object| google_tag_manager object| google_tag_data function| onYouTubeIframeAPIReady object| gaGlobal object| smooth object| ElementorProFrontendConfig object| elementorFrontendConfig function| generateStickyDebounce object| gpscroll function| once undefined| $ function| jQuery function| SmoothScroll function| GLightbox object| NiceScroll object| wp function| EvEmitter function| imagesLoaded object| webpackChunkelementor object| __core-js_shared__ object| core object| elementorModules function| Sticky object| elementorProFrontend object| DialogsManager function| Waypoint function| ShareLink function| Swiper object| elementorFrontend object| _wpemojiSettings function| _ object| Backbone object| drupalSettings object| Drupal object| tabbable function| DataTable function| loadjs function| Cookies object| _satellite boolean| __satelliteLoaded object| adobe function| Visitor object| s_c_il number| s_c_in string| urhehlevkedkilrobacf number| _dataLayerOverwriteMonitor function| AppMeasurement_Module_ActivityMap function| AppMeasurement function| s_gi function| s_pgicq object| internals boolean| isInternal object| s number| s_objectID number| s_giq object| s_i_trcgsuzhouconnectbiopharmaceuticals_trcgclientwebglobal object| twemoji object| originalsizes

6 Cookies

Domain/Path Name / Value
.connectbiopharm.com/ Name: _ga
Value: GA1.1.746833759.1717317853
.connectbiopharm.com/ Name: _ga_2BTFV1CHSX
Value: GS1.1.1717317853.1.1.1717317853.0.0.0
.connectbiopharm.com/ Name: AMCVS_98CF678254E93B1B0A4C98A5%40AdobeOrg
Value: 1
.connectbiopharm.com/ Name: AMCV_98CF678254E93B1B0A4C98A5%40AdobeOrg
Value: 179643557%7CMCMID%7C24604395002450466310463618449650533049%7CMCAAMLH-1717922653%7C6%7CMCAAMB-1717922653%7C6G1ynYcLPuiQxYZrsz_pkqfLG9yMXBpb2zX5dvJdYQJzPXImdj0y%7CMCOPTOUT-1717325053s%7CNONE%7CvVersion%7C5.5.0
.connectbiopharm.com/ Name: s_cc
Value: true
.connectbiopharm.com/ Name: ak_bmsc
Value: 53E49B06D984DC51969FB6E77030153E~000000000000000000000000000000~YAAQrJMRAgEdZ7uPAQAA6uIe2Bf56S+sPuiS96cD9QYeJ83org24UepaHagYGIvRD/6pX5czeW6go4MxRmzVYaY9gK/p9Hya0UogZ1pc17uW0UoPDnLtB0igXAviN9zHN6zAXJhMF/X0swN2VoAjZcacPnhjjhptUo6WkoHunYKsZupDh/AFmtqpJJQRZL9O7HNWUp3+bKe35MmjDknLO194P+8jlqt+E1m4p2uryBQDuZWa+cQ3SaZ902G9D+hbqCfSDD1NUzm1bUq7EeSDWGw4MVIvStD9vn7HBSj/MITNCTK7N6f1yiCTfl/RlnSlpumNL/vfFnCEgWIEdTxC1hk+qB9LRL1h4fOec79N/Ty9S2CUaFzUm6ogu3EtrXZsTeZNA94Ab2QyeeMKW+yh+Awms2fnLTsoS6cmKuwvpdXHdHKvqcsf2ouqfreg/jiLXvakOziTu5GF6KAVEClmwucX

6 Console Messages

Source Level URL
Text
security warning
Message:
Error with Feature-Policy header: Unrecognized feature: 'ambient-light-sensor'.
security warning
Message:
Error with Feature-Policy header: Unrecognized feature: 'speaker'.
security warning
Message:
Error with Feature-Policy header: Unrecognized feature: 'vibrate'.
security warning
Message:
Error with Feature-Policy header: Unrecognized feature: 'vr'.
deprecation warning URL: https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/js/js_iKZ_wA6wamDFIPceQWfMUCuvtEXn34ZCEbEzjUa-v4Q.js?scope=footer&delta=0&language=en&theme=nir_pid3975&include=eJyVkmtOwzAMxy-0tRIIIc7BAaI8vNY0tYfjbhqnx32ItduQQP2Q-Od__YoJxcUOEiqLS17tCxlKfb3uyCS9lw50EriQOXZ1D56cQOS-BzKOTC62XvQXvSefL0WdmJQaF7z8Q17cVMsuskCdZDj6_A46edasOgo3AmWpeciKvbXm6625KxYZ-jr4ApNyvNQFk1yt8YKRaYn_8TmAXKoBqyMXHJu95RY3czPTnhMI4ZdsilMeYgsnIC17haKbCExxXQtkiPpUZQzi5XLnuAJTzHGQ1HJamoEseRnZjSP42AUm2ClztvnXy1nZAw530JPi_pDRlkNundsxreERn99eX-qY0dpckzOmBqzxsd4Zp4nzCUQwwQbOv-9b8NbKI8-BWW88vyWweSeepWcI9nbgiBWj7fgDVi3npJ920MxZ-WNVPnEAl_1Asf2D0JYyfQMmlE9n(Line 30)
Message:
Listener added for a 'DOMNodeInserted' mutation event. This event type is deprecated, and will be removed from this browser very soon. Usage of this event listener will cause performance issues today, and represents a large risk of future site breakage. Consider using MutationObserver instead. See https://chromestatus.com/feature/5083947249172480 for more information.
deprecation warning URL: https://investors.connectbiopharm.com/sites/g/files/knoqqb83566/files/js/js_7ThKeh1ra5zJdIlm-qhMOlvW6Zo3poudDmDYt5FVfSo.js?scope=header&delta=1&language=en&theme=nir_pid3975&include=eJyVkmtOwzAMxy-0tRIIIc7BAaI8vNY0tYfjbhqnx32ItduQQP2Q-Od__YoJxcUOEiqLS17tCxlKfb3uyCS9lw50EriQOXZ1D56cQOS-BzKOTC62XvQXvSefL0WdmJQaF7z8Q17cVMsuskCdZDj6_A46edasOgo3AmWpeciKvbXm6625KxYZ-jr4ApNyvNQFk1yt8YKRaYn_8TmAXKoBqyMXHJu95RY3czPTnhMI4ZdsilMeYgsnIC17haKbCExxXQtkiPpUZQzi5XLnuAJTzHGQ1HJamoEseRnZjSP42AUm2ClztvnXy1nZAw530JPi_pDRlkNundsxreERn99eX-qY0dpckzOmBqzxsd4Zp4nzCUQwwQbOv-9b8NbKI8-BWW88vyWweSeepWcI9nbgiBWj7fgDVi3npJ920MxZ-WNVPnEAl_1Asf2D0JYyfQMmlE9n(Line 16)
Message:
Listener added for a 'DOMSubtreeModified' mutation event. This event type is deprecated, and will be removed from this browser very soon. Usage of this event listener will cause performance issues today, and represents a large risk of future site breakage. Consider using MutationObserver instead. See https://chromestatus.com/feature/5083947249172480 for more information.

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

assets.adobedtm.com
bam.nr-data.net
dpm.demdex.net
fonts.googleapis.com
fonts.gstatic.com
investors.connectbiopharm.com
js-agent.newrelic.com
ml.globenewswire.com
region1.google-analytics.com
thomsonreuterscorporategroupweb.sc.omtrdc.net
use.fontawesome.com
www.connectbiopharm.com
www.googletagmanager.com
162.247.243.29
2001:4860:4802:34::36
2602:816:5001::39
2606:4700:3037::ac43:8ef5
2a00:1450:4001:810::2003
2a00:1450:4001:812::200a
2a00:1450:4001:82f::2008
2a02:26f0:3500:591::1e80
2a02:26f0:e300::211:93b0
2a02:26f0:e300::211:93c0
35.190.31.54
54.76.80.14
63.140.62.27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